Skip to main content

Annual General Meeting in ALK-Abelló A/S held on 23 March 2023

ALK (ALKB:DC / OMX: ALK B / AKBLF): ALK-Abelló A/S held its Annual General Meeting on 23 March 2023.

The Annual General Meeting transacted the following business:

  • Adoption of the annual report 2022 and discharge of the Board of Directors and Board of Management
  • No declaration of ordinary dividend in accordance with the approved annual report for 2022
  • Adoption of the remuneration report for 2022
  • Adoption of the remuneration to the Board of Directors for the present year
  • Re-election of Anders Hedegaard as the Chair of the Board of Directors
  • Re-election of Lene Skole as the Vice Chair of the Board of Directors
  • Re-election of Gitte Aabo, Lars Holmqvist, Bertil Lindmark and Alan Main as well as new election of Jesper Høiland to the Board of Directors
  • Re-appointment of PwC Statsautoriseret Revisionspartnerselskab as the company’s auditor
  • Adoption of the following proposals from the Board of Directors:

            (a)   Renewed authority to the Board of Directors to purchase treasury shares

            (b)   Removal of Article 4.3 in the Articles of Association (the Company’s keeper of the shareholders’ register)

            (c)   Update of the remuneration policy

            (d)   Authorisation to the chair of the meeting

ALK-Abelló A/S

        

For further information please contact:

Anders Hedegaard, Chair, tel. +45 4574 7576

About ALK
ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,700 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net.

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.